Invention Grant
- Patent Title: Peptides and methods for the treatment of diabetes
-
Application No.: US17019695Application Date: 2020-09-14
-
Publication No.: US11407795B2Publication Date: 2022-08-09
- Inventor: Luc Vander Elst , Vincent Carlier , Jean-Marie Saint-Remy
- Applicant: IMCYSE SA
- Applicant Address: BE Liège
- Assignee: IMCYSE SA
- Current Assignee: IMCYSE SA
- Current Assignee Address: BE Liège
- Agency: Nixon & Vanderhye, PC
- Priority: EP17160085 20170309
- Main IPC: C07K14/435
- IPC: C07K14/435 ; A61P3/10 ; A61K35/17 ; C07K7/08 ; A61K38/00
Abstract:
The invention relates to peptides such as HCPYCSLQPLALEGSLQKRG [SEQ ID NO: 26] and their use in the treatment of type 1 diabetes and the generation of cytolytic CD4+ T cell.
Information query
